Patents by Inventor Ann Harris

Ann Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MicroRNA treatment of fibrosis
    Patent number: 9856481
    Abstract: Provided herein are microRNAs that target transforming growth factor beta (TGF-?) receptors and attenuate pathways of fibrosis. In particular, microRNA-1343 reduces expression of TGFBR1 and TGFBR2, decreases TGF-? signaling, represses pathways of fibrosis, and treats fibrotic diseases.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: January 2, 2018
    Assignee: Ann & Robert H. Lurie Children's Hospital
    Inventors: Ann Harris, Lindsay R. Stolzenburg
  • MICRORNA TREATMENT OF FIBROSIS
    Publication number: 20170067061
    Abstract: Provided herein are microRNAs that target transforming growth factor beta (TGF-?) receptors and attenuate pathways of fibrosis. In particular, microRNA-1343 reduces expression of TGFBR1 and TGFBR2, decreases TGF-? signaling, represses pathways of fibrosis, and treats fibrotic diseases.
    Type: Application
    Filed: August 12, 2016
    Publication date: March 9, 2017
    Inventors: Ann Harris, Lindsay R. Stolzenburg
  • CFTR gene regulator
    Publication number: 20030229045
    Abstract: The invention relates to a novel CFTR gene regulatory element capable of increasing the activity of the CFTR gene promoter, and to nucleic acid constructs comprising the element together with the CFTR gene coding region. The element and constructs containing it are useful in gene therapy for treating cystic fibrosis.
    Type: Application
    Filed: April 7, 2003
    Publication date: December 11, 2003
    Applicant: ISIS INNOVATION LIMITED
    Inventor: Ann Harris
  • CFTR gene regulator
    Patent number: 6573073
    Abstract: The invention relates to a novel CFTR gene regulatory element capable of increasing the activity of the CFTR gene promoter, and to nucleic acid constructs comprising the element together with the CFTR gene coding region. The element and constructs containing it are useful in gene therapy for treating cystic fibrosis.
    Type: Grant
    Filed: September 18, 1998
    Date of Patent: June 3, 2003
    Assignee: Isis Innovation Limited
    Inventor: Ann Harris
  • CFTR GENE REGULATOR
    Publication number: 20020086836
    Abstract: The invention relates to a novel CFTR gene regulatory element capable of increasing the activity of the CFTR gene promoter, and to nucleic acid constructs comprising the element together with the CFTR gene coding region. The element and constructs containing it are useful in gene therapy for treating cystic fibrosis.
    Type: Application
    Filed: September 18, 1998
    Publication date: July 4, 2002
    Inventor: ANN HARRIS